Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment.
- Author:
Brittany C PARKER
1
;
Wei ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Chromosomal Instability; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Neoplasms; diagnosis; genetics; therapy; Oncogene Proteins, Fusion; genetics; Oncogenes; Recombination, Genetic; genetics; Translocation, Genetic; genetics
- From:Chinese Journal of Cancer 2013;32(11):594-603
- CountryChina
- Language:English
- Abstract: Studies over the past decades have uncovered fusion genes, a class of oncogenes that provide immense diagnostic and therapeutic advantages because of their tumor-specific expression. Originally associated with hemotologic cancers, fusion genes have recently been discovered in a wide array of solid tumors, including sarcomas, carcinomas, and tumors of the central nervous system. Fusion genes are attractive as both therapeutic targets and diagnostic tools due to their inherent expression in tumor tissue alone. Therefore, the discovery and elucidation of fusion genes in various cancer types may provide more effective therapies in the future for cancer patients.
